trending Market Intelligence /marketintelligence/en/news-insights/trending/nrjccwum0pg7ffqjk5odma2 content esgSubNav
In This List

Humanigen appoints chief medical officer

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Humanigen appoints chief medical officer

Brisbane, Calif.-based Humanigen Inc. named Tarek Sahmoud as its chief medical officer.

Sahmoud consults a number of chimeric antigen receptor T cell therapy companies on their clinical and regulatory plans.

He recently served as the chief medical officer for Eisai Co. Ltd.'s unit H3 Biomedicine Inc., a biopharmaceutical company engaged in the discovery and development of small-molecule drugs to treat cancer.

Humanigen is developing CAR-T optimization and cancer treatments.